EnPlusOne Biosciences
Homepage - EnPlusOne Bio
Watertown, United States · $22.0M raised
- Headquarters
- Watertown, Massachusetts
- Employees
- 1–10
- Business Model
- B2B
- Website
- enplusone.bio
- Total Funding
- $22.0M
- Last Round
- $10.0M SeedFeb 2025
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
EnPlusOne Bio addresses an urgent need in RNA therapeutics manufacturing, where current chemical synthesis technologies cannot keep pace with demand. While nature encodes more than 200 RNA modifications, chemical synthesis can only access about 20 of them. EnPlusOne's solution is a flexible enzymatic platform that unlocks greater scale and access to new RNA therapeutics.
Summary
EnPlusOne Biosciences is a Biotech company based in Watertown, United States. It has raised $22.0M in total across 2 rounds, most recently a $10.0M Seed round in Feb 2025. Investors include Northpond Ventures and Breakout Ventures.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Feb 2025
Sign up to see all 2 events
Funding: Seed. Amounts, valuations, and investors where available.
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/enplusone-biosciences"><img src="https://indexed.vc/api/badge/company/enplusone-biosciences" alt="EnPlusOne Biosciences on Indexed.vc" width="260" height="76" /></a>